CRISPR gene-editing treatment could reach patients ‘very, very soon’: Intellia CEO
July 02, 2021 at 10:46 AM EDT
The trial success of CRISPR gene-editing technology has broad applications to treating other diseases, Intellia Therapeutics CEO John Leonard said.
